Stimulus-responsive hybrid nanoparticles based on multiple lipids for the co-delivery of doxorubicin and Sphk2-siRNA and breast cancer therapy
Food Chem Toxicol. 2022 Nov 28:113532. doi: 10.1016/j.fct.2022.113532. Online ahead of print.NO ABSTRACTPMID:36455683 | DOI:10.1016/j.fct.2022.113532
Source: Food and Chemical Toxicology - Category: Food Science Authors: Jinying Liang Shiqi Guo Mengxin Bai Mengying Huang Yupeng Qu Ying Zhao Yu Song Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Chemistry | Food Science | Men | Nanotechnology | Toxicology